The estimated Net Worth of Jason A. Leverone is at least $1.66 Million dollars as of 13 March 2020. Mr. Leverone owns over 11,249 units of Miragen Therapeutics Inc stock worth over $1,123,555 and over the last 8 years he sold MGEN stock worth over $0. In addition, he makes $533,223 as Principal Financial Officer, Principal Accounting Officer, Treasurer und Secretary at Miragen Therapeutics Inc.
Sign up
Mr. Leverone MGEN stock SEC Form 4 insiders trading
Jason has made over 3 trades of the Miragen Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 11,249 units of MGEN stock worth $6,412 on 13 March 2020.
The largest trade he's ever made was exercising 29,530 units of Miragen Therapeutics Inc stock on 7 August 2018 worth over $16,832. On average, Jason trades about 4,875 units every 65 days since 2017. As of 13 March 2020 he still owns at least 48,829 units of Miragen Therapeutics Inc stock.
You can see the complete history of Mr. Leverone stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jason Leverone biography
Jason A. Leverone CPA serves as Principal Financial Officer, Principal Accounting Officer, Treasurer, Secretary of the Company. Mr. Leverone joined Private Miragen in November 2008 as its senior director of finance and operations and was appointed vice president, finance in March 2010. Mr. Leverone was appointed as Private Miragen’s chief financial officer in February 2012. Prior to joining Private Miragen, Mr. Leverone was senior director of finance and controller for Replidyne, Inc., a publicly-traded biotechnology company, from November 2005 to November 2008. Prior to joining Replidyne, Mr. Leverone was the corporate controller for CreekPath System, Inc., an international software development company, from September 2002 to October 2005. He commenced his professional career with the accounting firm of Ernst and Young LLP, where he last served as a senior accountant, and then Arthur Andersen LLP, where he last served as an audit manager. Mr. Leverone is a Certified Public Accountant and earned a B.S. in Business Administration from Bryant University.
What is the salary of Jason Leverone?
As the Principal Financial Officer, Principal Accounting Officer, Treasurer und Secretary of Miragen Therapeutics Inc, the total compensation of Jason Leverone at Miragen Therapeutics Inc is $533,223. There are 1 executives at Miragen Therapeutics Inc getting paid more, with Diana Escolar having the highest compensation of $543,788.
How old is Jason Leverone?
Jason Leverone is 46, he's been the Principal Financial Officer, Principal Accounting Officer, Treasurer und Secretary of Miragen Therapeutics Inc since 2019. There are 6 older and 3 younger executives at Miragen Therapeutics Inc. The oldest executive at Miragen Therapeutics Inc is Arlene Morris, 68, who is the Independent Director.
What's Jason Leverone's mailing address?
Jason's mailing address filed with the SEC is C/O MIRAGEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER, CO, 80301.
Insiders trading at Miragen Therapeutics Inc
Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over $636,110 worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth $5,368,137 . The most active insiders traders include Bennett S Lebow, Bruce Booth und Paul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of $2,345,685. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth $2,268,935.
What does Miragen Therapeutics Inc's logo look like?
Complete history of Mr. Leverone stock trades at Miragen Therapeutics Inc
Miragen Therapeutics Inc executives and stock owners
Miragen Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Diana Escolar,
Chief Medical Officer -
Jason Leverone,
Principal Financial Officer, Principal Accounting Officer, Treasurer, Secretary -
Jeffrey Hatfield,
Independent Chairman of the Board -
Joseph Turner,
Independent Director -
Arlene Morris,
Independent Director -
Christopher Bowden,
Independent Director -
Tomas Kiselak,
Director -
Peter Harwin,
Director -
Lee Rauch,
Chief Executive Officer, Director -
Jonathan Violin,
President, Chief Operating Officer -
Bruce Booth,
Director -
Kyle Lefkoff,
Director -
Paul D Rubin,
EVP, Research & Development -
Adam Scott Levy,
Chief Business Officer -
Thomas E. Hughes,
Director -
Bennett S Lebow,
Director -
Global Master Fund Lp Logos,
10% owner -
John W Creecy,
Director -
Kevin Koch,
Director -
Funds Management Llc Fairmo...,
-
William Stuart Marshall,